Adar Poonawalla, Serum Institute of India CEO (Dhiraj Singh/Bloomberg via Getty Images)

April 25, 2023 03:00 PM EDT

Serum Institute subsidiary invests another $150M into Biocon

Tyler Patchen

News Reporter

Biosimilar manufacturer Biocon said Tuesday that the Serum Institute of India is making another $150 million investment, doubling a prior investment from last November. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Serum Institute subsidiary invests another $150M into Biocon

Tyler Patchen

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Aligos’ trial for oral MASH treatment succeeds, but placebo group shows odd trend

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Stem cell startup spun out of George Church’s lab raises $75M

Breaking down silos with a new quantitative approach to drug development

Serum In­sti­tute sub­sidiary in­vests an­oth­er $150M in­to Bio­con

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Serum Institute subsidiary invests another $150M into Biocon